NASDAQ · AHG

Akso Health Group

$1.46 -$0.05 (-3.31%) 1D Market open

Key Metrics

$1.29B
Market cap
P/E · TTM
$14.78M
Revenue · TTM
−$134.98M
Net income
EPS · TTM $-0.08
Dividend yield
Free cash flow $7.23M
Beta · 1Y -0.35
EBITDA · TTM
Gross margin -1.9%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 15
    From its Mar 13 high, the share price fell 54%.

    Peak close $2.50 on Mar 13; trough close $1.16 on Jun 15. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -54%
  • Mar 11
    The stock moved +23.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 11
  • Mar 10
    The stock moved +20.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 10

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$1.29B
Enterprise value
Shares outstanding856.7M
52-wk range$1.10 – $2.50
Avg volume · 20D76.2K
Net cash
Book value / share$0.11
ExchangeNASDAQ
About Akso Health Group
IPO dateNov 3, 2017
Employees27

Akso Health Group is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S87.54
P/FCF178.92
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross -1.9%
Operating -1,125.1%
Net -913.4%
FCF 48.9%
ROE / ROIC -80.2% · -72.4%

Financial Health

Current ratio1.53
Quick ratio1.51
Debt / equity
Debt / EBITDA
Net cash
Working capital$6.37M

Cash Flow · TTM

Operating CF $7.26M
Capex −$26.26K
Free cash flow $7.23M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

52.7
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2025-09-30 · computed by TickerWolf from SEC filings